MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BEN-PORAT, T.
Right arrow Articles by KAPLAN, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BEN-PORAT, T.
Right arrow Articles by KAPLAN, A. S.

Molecular Pharmacology, Vol 4, 139-146, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Effect of 1-beta-D-Arabinofuranosylcytosine on DNA Synthesis

II. In Rabbit Kidney Cells Infected with Herpes Viruses

TAMAR BEN-PORAT 1, MCKAY BROWN 1, and ALBERT S. KAPLAN 1

1 Department of Microbiology, Research Laboratories, Albert Einstein Medical Center, Philadelphia, Pennsylvania 1941

1-beta-D-Arabinofuranosylcytosine (Ara-C) inhibits the synthesis of DNA in noninfected rabbit kidney cells to a greater degree than in cells infected with viruses of the herpes group (herpes simplex and pseudorabies viruses). Virus multiplication is inhibited by the drug to the same extent as DNA synthesis, demonstrating that Ara-C interferes with the infective process by inhibiting the synthesis of DNA only.

The relative resistance of infected cells to the action of the drug is probably due to the lower ability of these cells as compared to noninfected cells to phosphorylate Ara-C. The low level of phosphorylation of the drug in the infected cells is correlated with a decrease in the activity of deoxycytidine kinase in vivo. Furthermore, the drug does not induce in the infected cells an increase in the level of activity of deoxycytidine kinase, an effect it does produce in noninfected cells. It is concluded that Ara-C is not a specific antiviral agent.

Note:
ACKNOWLEDGMENTS This investigation was supported by grants from the National Institutes of Health (AI-03362) and from the National Science Foundation (GB-4995), and by a U.S. Public Health Research Career Program Award (5-K3-AI-l9,335) from the National Institute of Allergy and Infectious Diseases.

Submitted on August 21, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics